Accessing the Legal Coca Trade

Medicine Hunter Chris Kilham recently secured direct access to Peru’s state-owned coca company, ENACO, to document the legal trade of the plant. This visit allowed him and his partner, Sergio Cam, to photograph production facilities and meet with local growers. While much of the world associates coca solely with the production of cocaine, the plant serves a traditional role in Andean culture. Kilham spent months coordinating with government officials to gain this rare look at the legal industry, which remains distinct from the illicit drug trade.

Kilham emphasizes a clear distinction between the whole leaf and the isolated cocaine alkaloid. He notes that people often fail to differentiate between a raw botanical ingredient and a concentrated, dangerous compound. By separating the coca leaf from the drug derived from its alkaloid, the industry has the potential to introduce new ingredients into the market. Peru currently cultivates approximately 220,000 tons of coca leaf annually, a massive output that powers the state-run legal trade.

Potential for the Supplement Industry

ENACO processes this vast harvest into various legal items, including tea, leaf powder, and both fluid and powdered extracts. Kilham believes these decocainized extracts hold promise for the global supplement sector. He identifies energy shots and functional beverages as primary candidates for the ingredient. The goal is to offer consumers a product that provides nutritional benefits without the illegal compounds often associated with the plant.

Beyond product development, there is a clear focus on the economic impact for farmers. The shift toward a formal legal market for these extracts could provide better stability for those working in the Andes. Kilham argues that the benefits must extend to the people who perform the backbreaking harvest. A shift in perception in the United States and elsewhere is required to move from stigma to potential health applications.

Overcoming Logistical Hurdles

Commercialization faces significant practical barriers. Major global shipping companies like FedEx, UPS, and DHL refuse to transport ENACO’s alkaloid-free extracts, citing their strict policies. This forces businesses to rely on more expensive alternatives, such as specialized air freight or ocean transit. Without a change in these logistics, wide distribution remains difficult for smaller supplement manufacturers.

Industry leaders are currently examining the history and legal trade of the plant through initiatives like the special coca issue of HerbalGram. Contributions from ethnobotanists such as Wade Davis and Dennis McKenna suggest that scientific interest in the plant is growing. If logistics can be smoothed out, the market may see a rise in legal coca-derived ingredients. The coming years will determine if these extracts move from a niche botanical curiosity into a standard shelf offering in the global health market.